Venturepharma
CDMO is Venturepharma
“Made in Asia” is the most outstanding
A CMO solution ranging from 500 tons of CGMP standard API to full formulation contract processing
12 wholly-owned &OEM factories for manufacturing excellence
Global pharmaceutical manufacturing provider
Production outsourcing services with complete quality control
The five production bases provide a wide range of production and packaging services for all dosage forms
Professional project managers, dedicated quality control and assurance teams
Four major API factories and two FDA-certified GMP factories are dedicated to the production of apis and intermediates
Venturepharma (Hainan) Pharmaceutical Base
Vante Pharmaceutical (Hainan) Co., Ltd. has 7 advanced active pharmaceutical ingredient and formulation production bases distributed across Asia, providing customers with comprehensive production outsourcing services from the early stage of product development to large-scale production. All production bases have passed GMP certification, among which two raw material drug production bases have been certified by the US FDA. With its production capacity, technological development capabilities and a complete management system, the company ensures timely and flexible production, saves costs for customers to the greatest extent and keeps their business secrets confidential.
As an advanced pharmaceutical enterprise in China, Wante Pharmaceutical Group keeps the high quality of products, and constantly infuses new technologies, new products and new talents to provide customers with the most preferential products and the most professional services, so as to meet and exceed the standards and expectations of customers. At present, Vante Pharmaceutical Group has more than 3000 outstanding employees.
Manufacturing Asia’s most outstanding drugs. Distributed in Asia, advanced API and formulation manufacturing base, providing integrated manufacturing outsourcing services for global pharmaceutical enterprises. Preparation production, technical services, clinical samples (preparation) services, API pilot scale up, industrialization services, super rapid release technology platform, global liquid technology platform.
The business scope of the company includes drug production, drug wholesale (business activities can only be carried out after the approval of the relevant departments) and technical services, technical development, technical consultation, technical exchange, technology transfer, technology promotion, etc. In addition, the company also involves the sale of chemical products (excluding licensed chemical products).
The main products of Vant Pharmaceutical (Hainan) Co., Ltd. cover a variety of treatment fields, including gynecology, neuropsychiatry, antihistamines, orthopedics, anti-infection, endocrine, cardiovascular and cerebrovascular, and are widely used in anti-allergy, brain science, addiction, rare diseases, gynecology, endocrine and other fields. The annual production capacity of the company is: 1 billion tablets, 100 million capsules, 50 million bags of granules, and 100 million bags of powder. Synthesis workshop can produce all kinds of chemical synthesis intermediates and raw materials, the annual output can reach 800Kg.
Venturepharma (Jiangsu) Pharmaceutical Base
Venturepharma Pharmaceutical Jiangsu Co., Ltd. is a pharmaceutical enterprise established on July 15, 2009, located at Building 5, No. 10 Xinglin Road, Taizhou City, Jiangsu Province (Pharmaceutical City). The registered capital of the company is 30 million yuan, and the legal representative is Guo Xia. As a small and micro enterprise, the business scope of Venturepharma Pharmaceutical Jiangsu Co., Ltd. includes the production of various drugs such as tablets, capsules, granules, powders, soft capsules, small volume injections, freeze-dried powder injections, and gels.
Venturepharma Pharmaceutical Jiangsu Co., Ltd. is affiliated to Wanquan Pharmaceutical Group, which is committed to providing production outsourcing service management for global pharmaceutical enterprises and has 7 advanced active pharmaceutical ingredient and formulation production bases distributed across Asia. The production bases of Venturepharma Pharmaceutical Jiangsu Co., Ltd. have all passed GMP certification, among which two raw material drug production bases have been certified by the US FDA.
Venturepharma Pharmaceutical Jiangsu Co., Ltd. maintains high-quality products while constantly injecting new technologies, new products and new talents to provide customers with favorable products and professional services, in order to meet and exceed customers’ standards and expectations. At present, the company has more than 1500 outstanding employees, committed to improving the health of China, so that the Chinese people enjoy the world’s leading drugs and the pursuit of health and beauty.
Excellence for global pharmaceutical enterprises to provide comprehensive production outsourcing services: intelligent drug delivery engineering technology transformation center, small molecule drug process transformation base, semi-solid/production and research experimental base, injection/production and research technology platform.
Venturepharma (Xiamen) Pharmaceutical Base
Venturepharma Pharmaceutical (Xiamen) Co., Ltd. is a pharmaceutical manufacturing enterprise located at No. 6, Yangtai Road, Xinyang Industrial Zone, Haicang District, Xiamen City, Fujian Province. The company was established on September 6, 2002, with a registered capital of RMB 17,811.658 million. The company’s main business covers the production of tablets, hard capsules (including class II psychotropic drugs), granules, raw materials and related supporting services.
This company is a wholly-owned subsidiary of Venturepharma Pharmaceutical Holding Group. The group was established in 1998 and is committed to enabling Chinese people to enjoy world-leading medicines and the pursuit of health and beauty. Venturepharma Pharmaceutical (Xiamen) Co., LTD., with its professional and international background as a pharmaceutical group, provides customers with comprehensive production outsourcing services ranging from the early stage of product development to large-scale production. All of the company’s manufacturing sites have passed the GMP certification, including two API production sites have been approved by the US FDA, and one drug product production site has been established in accordance with cGMP standards.
Venturepharma Pharmaceutical (Xiamen) Co., LTD., with its production capacity, technological development capabilities and complete management system, ensures timely and flexible production, saves costs for customers to the greatest extent, and keeps their business secrets confidential. While maintaining the high quality of products, the company continues to inject new technologies, new products and new talents to provide customers with preferential products and professional services to meet and exceed the standards and expectations of customers.
The world’s three major anti-AIDS drug production bases and Clinton Foundation cooperation units through the international WHO certification: Marine drug Research Center, small molecule industrialization engineering technology Center, solid preparation registration sample service.
